BioAffinity Technologies Secures Patent for Novel Cancer Therapy Targeting CD320 and LRP2 Receptors
On Wednesday, BioAffinity Technologies Inc. (NASDAQ:BIAF) announced that the US Patent and Trademark Office/USPTO has issued a new patent. The patent is titled "Compositions and Methods for Treating Cancer," and covers a novel method and composition for selectively eliminating cancer cells by targeting the CD320 and LRP2 receptors on the cell membrane.
The therapeutic approach outlined in the patent applies to a broad spectrum of cancers, including those of the lung, breast, prostate, brain, and skin. BioAffinity Technologies has already initiated research towards developing a topical treatment for skin cancers. The new patent supports the company's intellectual property portfolio, which now includes 19 awarded US and foreign patents and 36 pending patent applications related to its diagnostic platform and cancer treatment therapeutics.
A medical professional in a hospital, using targeted cancer therapuetics to treat cancer patients.
The invention utilizes small interfering RNAs (siRNAs) to suppress the expression of CD320 and LRP2 proteins. In vitro studies have demonstrated that the simultaneous knockdown of both proteins is selectively cytotoxic to human cancer cells, while sparing normal cells under the same treatment conditions. The studies also indicated that the double knockdown of CD320 and LRP2 is crucial, as down-regulating only one receptor led to increased protein expression in the other, and was insufficient to kill cancer cells or significantly inhibit their proliferation.
BioAffinity Technologies Inc. (NASDAQ:BIAF) develops non-invasive diagnostics to detect early-stage lung cancer and other diseases of the lung using flow cytometry and automated analysis in the US. It operates through two segments: Diagnostic R&D and Laboratory Services.
While we acknowledge the potential of BIAF to grow, our conviction lies in the belief that some AI stocks hold greater promise for delivering higher returns and have limited downside risk. If you are looking for an AI stock that is more promising than BIAF and that has 100x upside potential, check out our report about the cheapest AI stock.
READ NEXT: and .
Disclosure: None. This article is originally published at Insider Monkey.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
23 minutes ago
- Yahoo
Rolls-Royce named winning bidder for UK small nuclear reactors
Rolls-Royce has won a competition to be the first company to try to build small modular nuclear reactors (SMRs) in the UK, as part of a government effort to push Britain to the frontier of nuclear energy technology. Great British Energy – Nuclear said on Tuesday that Rolls-Royce SMR was the preferred bidder for the programme, after a drawn-out competition that pitted the FTSE 100 manufacturer against two US-owned companies. The state-owned power company's announcement came as part of a broader push for nuclear power by the government, as it promised to invest £14.2bn to build the large Sizewell C power station in Suffolk. Related: Sizewell C power station to be built as part of UK's £14bn nuclear investment The nuclear investments will form a key part of the spending review due to be announced by the chancellor, Rachel Reeves, on Wednesday as the government tries to shift attention from a U-turn on winter fuel payments for pensioners. Sizewell C will produce 3.2 gigawatts (GW) of power, enough for about 6m homes. By contrast, Rolls-Royce's SMRs will provide about 470 megawatts each. A separate government release said SMRs would collectively generate up to 1.5GW of electricity, suggesting that Rolls-Royce will be granted permission to build at least three SMRs. The crucial difference between large plants such as Sizewell C and the mini nuclear sites is that SMRs will mostly be built to a single design on a factory line, rather than individually on-site. Those factory-built 'modules' will then be fitted together at the site, in an effort to make the construction of nuclear plants cheaper, less complex and less prone to the hugely costly delays that have plagued the Hinkley Point C plant. The SMR approach is unproven, with no sites yet fully operational anywhere in the world. They are also likely to face local and national opposition. The Green party on Tuesday said that nuclear power was slow and expensive. However, Rolls-Royce has argued that the pressurised water reactor technology it has chosen is well understood, and will allow it to start generating power by 2032 at the earliest. Datacentres for tech companies are a key target customer. Ed Miliband, the energy secretary, said: 'We are ending the no-nuclear status quo as part of our plan for change and are entering a golden age of nuclear with the biggest building programme in a generation.' The government did not reveal the locations of the first UK SMRs, which some in the industry had hoped for to speed the process along. They are likely to be sited beside retired nuclear power stations such as Oldbury in Gloucestershire and Wylfa in north Wales. Derby-based Rolls-Royce beat competition from the US companies Holtec and GE Hitachi, while the Canadian-owned Westinghouse dropped out of the competition earlier. Rolls-Royce SMR was always considered by far the favourite. The company is majority-owned by Rolls-Royce, with other investors including Qatar's sovereign wealth fund, BNF Resources controlled by France's Perrodo family, whose wealth stems from fossil fuels, the US energy company Constellation, and the Czech utility CEZ. The decision will nevertheless represent a further boost for Rolls-Royce, which saw its share price hit a record high this month, making it Britain's biggest manufacturer by market value. Rolls-Royce's share price rose 2.4% on Tuesday to hit a new record high of £9.12. The company has benefited from the recovery in demand for its jet engines, the increase in defence spending prompted by Russia's invasion of Ukraine, as well as efforts to renegotiate contracts by the chief executive, Tufan Erginbilgiç. Erginbilgiç said: 'This is a very significant milestone for our business and Rolls-Royce SMR. It is a vote of confidence in our unique nuclear capabilities, which will be recognised by governments around the world.' The decision to try to build SMRs has been subject to years of delay. Rolls-Royce first submitted a design proposal in 2015 in the hope of building the first reactor in 2025. That target date kept slipping back as Rolls-Royce awaited approval under Conservative and now Labour governments. The government said the move would create 3,000 jobs at the peak of construction, grow regional economies and strengthen energy security. It will aim for 70% of the parts to be based in the UK, although the delay has already meant Rolls-Royce has chosen a non-UK supplier for crucial pressure vessels. While the UK is due to get the first reactor, Rolls-Royce has already agreed to produce an SMR in the Czech Republic, and it is in the final two in a competition in Sweden.
Yahoo
24 minutes ago
- Yahoo
Amid cost pressures, US employers are shifting their benefit strategy, WTW survey finds
More companies expanding choice, tackling high cost and reallocating benefit spend NEW YORK, June 10, 2025 (GLOBE NEWSWIRE) -- As U.S. employers grapple with heightened economic uncertainty and greater financial pressures on budgets, steering the right course on benefit strategy is more challenging than ever. This is according to a survey by WTW (NASDAQ: WTW), a leading global advisory, broking and solutions company. As a result, companies are turning to smarter spending, sharper focus and using benefits as a strategic tool to drive engagement, retention and purpose. The 2025 Benefits Trends Survey found rising benefit costs to be the top issue (90%) influencing U.S. employers' benefit strategies in 2025, up from 67% in 2023. Other top concerns include competition for talent (52%), expectations for an enhanced employee experience (43%), cost of living (39%) and rising mental health issues (32%). 'After a long period of high benefits inflation and in the face of a possibly weakening economy, employers are taking a step back and looking to focus on what drives real value for employees and the business. That means targeting support and spending on the benefits that matter most, enabling personalization and helping employees make better decisions,' said Jeff Levin-Scherz, Population Health Leader, North America, Health & Benefits. As the cost of medical care continues to show double digit growth in the U.S., employers face greater challenges in delivering their strategy in key areas such as health benefits (44%), wellbeing programs (44%), and leave benefits (36%). To address these concerns, employers are shifting their strategy. Few are expanding their benefit portfolio, choosing to instead focus on extracting value from their current offerings and improve financing, employee experience, analytics and administration. Compared to just 8% in the past year, 63% of employers plan to reallocate or rebalance spend in the next three years. A majority (73%) plan to tackle high costs by enhancing value or switch to better-value vendors across health, retirement and risk benefits. Just under half (44%) plan to tackle high-cost medical conditions and 37% plan to adopt a network of preferred medical providers. Eager to address employee pressure points, companies are also looking to improve the following priority areas over the next three years: maximizing value, mental health, health benefits, financial wellbeing and family support. Many plan to increase their use of communication and use nudges and navigation solutions to influence behaviors and enhance the employee experience. Regularly reviewing vendor performance, including employee feedback, is also a key action employers are taking. 'Organizations are facing more pressure than ever to deliver the right benefits strategy. Finding innovative solutions for old and new challenges and reallocating spend on benefits that deliver true value is a good start. There is still a long way to go to address these pressure points, but employers are headed in the right direction by focusing on what matters most to their employees,' said Levin-Scherz. About the survey The 2025 Benefit Trends Survey was conducted from early March to mid-April. Respondents include 696 U.S. employers, representing a broad range of industries in both the private and public sector. About WTW At WTW (NASDAQ: WTW), we provide data-driven, insight-led solutions in the areas of people, risk and capital. Leveraging the global view and local expertise of our colleagues serving 140 countries and markets, we help organizations sharpen their strategy, enhance organizational resilience, motivate their workforce and maximize performance. Working shoulder to shoulder with our clients, we uncover opportunities for sustainable success—and provide perspective that moves you. Media contactIleana Feoli: +1 212 309
Yahoo
29 minutes ago
- Yahoo
Terahertz Technology Market Forecasts Report 2025-2030, Featuring Major Players - TeraView, TOPTICA Photonics, HUBNER, Advantest, Batop, Terasense, and Microtech Instrument
Global Terahertz Technology Market to Propel at 14.55% CAGR, Reaching $2.37 Billion by 2030, driven by defense, security, and pharmaceutical applications. Key players include TeraView, TOPTICA, and Advantest. Explore insights into market growth, trends, strategies, and geographical analysis. Global Terahertz Technology Market Dublin, June 10, 2025 (GLOBE NEWSWIRE) -- The "Terahertz Technology Market - Forecasts from 2025 to 2030" has been added to offering. The global terahertz technology market is set to experience substantial growth, projected to expand at a CAGR of 14.55%, reaching US$2.37 billion by 2030, up from US$1.20 billion in 2025 This impressive growth is primarily driven by the escalating need for efficient security systems across diverse industries, coupled with rising research and development investments from defense sectors worldwide. The surging demand for security screening equipment in public domains further accelerates market expansion. The pharmaceutical sector's increasing uptake of terahertz technology also contributes significantly to market growth. This technology assesses coating integrity, identifies chemical and physical attributes, and detects impurities within the sector. Furthermore, the growing need for compact, energy-efficient transceivers and the expansion of terahertz technology applications in medical science, biology, and research laboratories propel market growth. Major industry players include TeraView Limited, TOPTICA Photonics AG, HUBNER GmbH & Co. KG, Advantest Corporation, Batop GmbH, Terasense Group Inc., and Microtech Instrument, Inc. Demand Surge for Terahertz Technology in Defense The defense sector's reliance on terahertz technology for addressing critical security challenges, such as detecting concealed explosives and hidden weapons, underpins market growth. Governments globally prioritize advanced detection systems, boosting terahertz technology integration in defense and security applications. The technology excels in military operations, ISR, and identifying isolated personnel, while in non-combat scenarios, THz spectroscopic imaging effectively detects concealed materials and enhances air surveillance systems. Diverse Industry Adoption Industries such as telecommunications, healthcare, and industrial testing increasingly adopt terahertz technology. In telecommunications, it enables high-speed data transfer and supports next-generation ultra-fast wireless system development. In healthcare, terahertz imaging aids in analyzing superficial body structures, cancer detection, and diagnosing dermatological conditions. Key Benefits of this Report: Insightful Analysis: Access comprehensive market insights across major and emerging regions, focusing on customer segments and industry verticals. Competitive Landscape: Gain understanding of global strategic maneuvers employed by key players. Market Drivers & Future Trends: Explore dynamic factors and pivotal market trends shaping future developments. Actionable Recommendations: Leverage insights for strategic decisions to unlock new business streams and revenues. Wide Audience Reach: Ideal for startups, research institutions, consultants, SMEs, and large enterprises. Key Attributes: Report Attribute Details No. of Pages 140 Forecast Period 2025 - 2030 Estimated Market Value (USD) in 2025 $1.2 Billion Forecasted Market Value (USD) by 2030 $2.37 Billion Compound Annual Growth Rate 14.5% Regions Covered Global Key Topics Covered: 1. EXECUTIVE SUMMARY2. MARKET SNAPSHOT2.1. Market Overview2.2. Market Definition2.3. Scope of the Study2.4. Market Segmentation3. BUSINESS LANDSCAPE3.1. Market Drivers3.2. Market Restraints3.3. Market Opportunities3.4. Porter's Five Forces Analysis3.5. Industry Value Chain Analysis3.6. Policies and Regulations3.7. Strategic Recommendations4. TECHNOLOGICAL OUTLOOK5. GLOBAL TERAHERTZ TECHNOLOGY MARKET BY TYPE5.1. Introduction5.2. Terahertz Imaging5.3. Terahertz Communication system5.4. Terahertz Spectroscopy6. GLOBAL TERAHERTZ TECHNOLOGY MARKET BY SOURCE6.1. Introduction6.2. Laser Source6.3. Semiconductor Source7. GLOBAL TERAHERTZ TECHNOLOGY MARKET BY END-USER7.1. Introduction7.2. Healthcare7.3. Food & Agriculture7.4. Defense & Security7.5. Others8. GLOBAL TERAHERTZ TECHNOLOGY MARKET BY GEOGRAPHY8.1. Introduction8.2. North America8.3. South America8.4. Europe8.5. Middle East and Africa8.6. Asia Pacific9. COMPETITIVE ENVIRONMENT AND ANALYSIS9.1. Major Players and Strategy Analysis9.2. Market Share Analysis9.3. Mergers, Acquisitions, Agreements, and Collaborations9.4. Competitive Dashboard10. COMPANY PROFILES10.1. TeraView Limited10.2. TOPTICA Photonics AG10.3. HUBNER GmbH & Co. KG10.4. Advantest Corporation10.5. Batop GmbH10.6. Terasense Group Inc.10.7. Microtech Instrument, Inc.10.8. Menlo Systems GmbH10.9. Gentec Electro-Optics10.10. Bakman Technologies10.11. TeraVil Ltd.10.12. Luna Innovations Incorporated For more information about this report visit About is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends. Attachment Global Terahertz Technology Market CONTACT: CONTACT: Laura Wood,Senior Press Manager press@ For E.S.T Office Hours Call 1-917-300-0470 For U.S./ CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900Error in retrieving data Sign in to access your portfolio Error in retrieving data
